Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men

@article{Blumeyer2011EvidencebasedG,
  title={Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men},
  author={Anja Blumeyer and Antonella Tosti and Andrew G. Messenger and Pascal Reygagne and V{\'e}ronique del Marmol and Phyllis I. Spuls and Myrto Georgia Trakatelli and Andreas M. Finner and Franklin Kiesewetter and Ralph M Tr{\"u}eb and Berthold Br Rzany and Ulrike Blume-Peytavi},
  journal={JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year={2011},
  volume={9}
}
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80 % Caucasian men and 42 % of women. 

Topics from this paper

Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
TLDR
The purpose of the guideline is to provide dermatologists with an evidence‐based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia. Expand
Androgenetic Alopecia: An Update of Treatment Options
TLDR
The current treatment alternatives for androgenetic alopecia including their efficacy, safety profile, and quality of evidence are discussed. Expand
Guidelines for management of androgenetic alopecia based on BASP classification–the Asian consensus committee guideline
  • W. S. Lee, H. Lee, +9 authors M. Zheng
  • Medicine
  • Journal of the European Academy of Dermatology and Venereology : JEADV
  • 2013
TLDR
There is currently no published AGA guideline for Asian patients, and in comparison with Caucasian patients, Asian patients with AGA have different types of hair loss and family histories which may alter the treatment response. Expand
Efficacy of platelet‐rich plasma in androgenetic alopecia patients
TLDR
This study aims to use platelet‐rich plasma (PRP) as an alternative treatment option for the AGA patients and shows promising results. Expand
Low‐level laser therapy as a treatment for androgenetic alopecia
TLDR
This paper aims to review the existing research studies to determine whether LLLT is an effective therapy for AGA based on objective measurements and patient satisfaction. Expand
Androgenetic Alopecia in Adolescents
Androgenetic alopecia (AGA) is a nonscarring progressive miniaturization of the hair follicle with a usually characteristic pattern distribution in genetically predisposed men and women. Although AGAExpand
Expert consensus on the management of Androgenetic Alopecia in India
TLDR
This review articulately summarizes the key opinions of the experts on all aspects of treatment for the effective management of AGA and provides the dermatologists with an evidence-based platform for choosing efficacious and safe therapy for patients with AGA. Expand
Addressing androgenetic alopecia–a complex disorder–with a multilateral treatment strategy
TLDR
Hair follicle miniaturization and variations in normal hair cycle cause gradual loss of hair in genetically predisposed individuals and leads to global reduction of hair density due to conversion of terminal hair into vellus hair. Expand
Pattern hair loss in men: diagnosis and medical treatment.
TLDR
Current understanding of the etiopathogenesis of hair loss in men, diagnostic tests available, and its medical management are discussed. Expand
Androgenetic Alopecia (AGA)
TLDR
A number of therapies are available to slow and reverse the progression of hair loss, and the distinct pattern of balding differs between the two. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 103 REFERENCES
S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents
TLDR
This S1 guideline for diagnostic evaluation of AGA in men, women and adolescents reviews the definition of AGA and presents expert opinion‐based recommendations for sex‐dependent steps in the diagnostic procedure. Expand
USE OF TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA IN WOMEN
TLDR
This study focuses on the treatment of hair loss in women withAndrogenetic alopecia, which begins as a diffuse and progressive thinning of the frontoparietal area of the scalp in women. Expand
[Alopecia androgenetica and its local treatment with estrogen- and corticosteroid externa].
TLDR
Treatment of androgenetic alopecia in 50 male and female patients with topical estorgens and corticosteroids with suggested that estrogens may limit the effect of endogenous testosterone in exhausting the hair follicle. Expand
Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial
TLDR
The effect of melatonin on hair growth in humans has not been investigated so far, but the effects of testosterone and dihydrotestosterone on the hair cycle are known to have an important role. Expand
Incidence of Female Androgenetic Alopecia (Female Pattern Alopecia)
  • O. Norwood
  • Medicine
  • Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2001
TLDR
Female androgenetic alopecia is quite common beginning in the late 20s and reaching its peak after 50 years of age. Expand
Androgenetic alopecia in adolescents.
TLDR
An overview of AGA is provided and new information on the prevalence and age at onset of hereditary hair thinning in adolescents is presented and data are presented on the efficacy and proper use of minoxidil topical solution in adolescent boys and girls. Expand
Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof‐of‐concept studies
TLDR
A topical formulation of fulvestrant was developed for the potential treatment of androgenetic alopecia based on preclinical studies in mice in which topical fulvestant caused telogen hair follicles to enter anagen, thereby causing hair growth. Expand
Male Androgenetic Alopecia
• Male balding is a common androgen-dependent trait in which there is a progressive decline in the activity and size of scalp hair follicles.
Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil.
TLDR
Topical minoxidil appears to be effective in helping to maintain nonvellus hair growth in men with androgenetic alopecia. Expand
Lokaltherapie der Alopecia androgenetica mit 17α-Östradiol
In a controlled, randomized double-blind study, 51 patients with androgenetic alopecia and increased hair loss (telogen rate > 20%) were treated by local application of hair lotions with and without 1
...
1
2
3
4
5
...